| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e2d59d62a514844fc5b0e743344d711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7817b2573160dc2388c37d980f776b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35d51d17accb05f0427d50e9cdcbf63e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00ff7c7b501ae52a33d0eef70003a0ec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-608
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-63 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00 |
| filingDate |
2010-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_699ed784da889f583ede2d83a242b493
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e604d88dfe07510fcda73c013705e6cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a17488dbddf3c07be276e43e1eb82bd |
| publicationDate |
2011-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010111232-A9 |
| titleOfInvention |
Drug delivery medical device |
| abstract |
Provided is a coated implantable medical device, comprising: a substrate; and a coating disposed on said substrate, wherein said coating comprises at least one polymer and at least one pharmaceutical agent in a therapeutically desirable morphology and/or at least one active biological agent and optionally, one or more pharmaceutical carrying agents; wherein substantially all of pharmaceutical agent and/or active biological agent remains within said coating and on said substrate until the implantable device is deployed at an intervention site inside the body of a subject and wherein upon deployment of said medical device in the body of said subject a portion of said pharmaceutical agent and/or active biological agent is delivered at said intervention site along with at least a portion of said polymer and/or a at least a portion of said pharmaceutical carrying agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11395891-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8834913-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8298565-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10661036-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9539593-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11318232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8636767-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10821240-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10034990-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8900651-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8852625-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8795762-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8758429-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111939312-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9510856-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9486431-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10195311-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497249-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9433516-B2 |
| priorityDate |
2009-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |